Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 119

Sort by

Sort Order Select

Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Blood Adv (2021) 5 (19): 3862–3872.

https://doi.org/10.1182/bloodadvances.2021004778

Published: 2021

Includes: Supplemental data

Journal Articles

Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia

Hasmukh Jain, Manju Sengar, Vasu Babu Goli, Jayashree Thorat, Prashant Tembhare, Dhanlaxmi Shetty, V. N. Avinash Bonda, Lingaraj Nayak, P. G. Subramanian, Bhausaheb Bagal, Nikhil Patkar, Neha Sharma, Himanshi Gupta, Sumeet Gujral

Blood Adv (2021) 5 (17): 3436–3444.

https://doi.org/10.1182/bloodadvances.2020003368

Published: 2021

Journal Articles

Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study

Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagarkar, Larry Kwak, Won-Seog Kim, SangJoon Lee, SungHyun Kim, KeumYoung Ahn, Michinori Ogura

Blood Adv (2021) 5 (17): 3354–3361.

https://doi.org/10.1182/bloodadvances.2021004484

Published: 2021

Includes: Supplemental data

Journal Articles

Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses

Brigitte T.A. van den Broek, Caroline A. Lindemans, Jaap Jan Boelens, Eveline M. Delemarre, Julia Drylewicz, Nanda Verhoeven-Duif, Peter M. van Hasselt, Stefan Nierkens

Blood Adv (2021) 5 (16): 3092–3101.

https://doi.org/10.1182/bloodadvances.2020003824

Published: 2021

Includes: Supplemental data

Journal Articles

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

Blood Adv (2021) 5 (14): 2901–2908.

https://doi.org/10.1182/bloodadvances.2020004144

Published: 2021

Includes: Supplemental data

Journal Articles

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher D’Angelo, Umar Farooq, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Yazdy, Emma Rabinovich, Frank A. Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A. Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M. Haverkos, Victor M. Orellana-Noia, Vaishalee P. Kenkre, Adam Zayac, Seth M. Maliske, Narendranath Epperla, Paolo Caimi, Scott E. Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A. Feldman, Daniel Rector, Stephen D. Smith, Andrzej Stadnik, Craig A. Portell, Yong Lin, Seema Naik, Silvia Montoto, Izidore S. Lossos, Kate Cwynarski

Blood Adv (2021) 5 (14): 2852–2862.

https://doi.org/10.1182/bloodadvances.2021004458

Published: 2021

Includes: Supplemental data

Journal Articles

Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study

Harinder Gill, Yammy Yung, Hiu-Tung Chu, Wing-Yan Au, Pui-Kwan Yip, Emily Lee, Rita Yim, Paul Lee, Daniel Cheuk, Shau-Yin Ha, Rock Y. Y. Leung, Edmond S. K. Ma, Cyrus R. Kumana, Yok-Lam Kwong

Blood Adv (2021) 5 (14): 2829–2838.

https://doi.org/10.1182/bloodadvances.2021004789

Published: 2021

Includes: Supplemental data

Journal Articles

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J. Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman

Blood Adv (2021) 5 (12): 2577–2585.

https://doi.org/10.1182/bloodadvances.2020004074

Published: 2021

Includes: Supplemental data

Journal Articles

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Béatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, Delphine Nollet, Damien Roos-Weil, Sylvie Chevret, Véronique Leblond

Blood Adv (2021) 5 (9): 2438–2446.

https://doi.org/10.1182/bloodadvances.2020003895

Published: 2021

Includes: Supplemental data

Journal Articles

Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism

Blood Adv (2021) 5 (8): 2237–2244.

https://doi.org/10.1182/bloodadvances.2020002398

Published: 2021

Includes: Supplemental data

Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora

Blood Adv (2021) 5 (8): 2153–2155.

https://doi.org/10.1182/bloodadvances.2021004284

Published: 2021

Journal Articles

Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study

Blood Adv (2021) 5 (7): 1837–1847.

https://doi.org/10.1182/bloodadvances.2020003453

Published: 2021

Includes: Supplemental data

Journal Articles

Involved-site radiotherapy for Helicobacter pylori –independent gastric MALT lymphoma: 26 years of experience with 178 patients

Joachim Yahalom, Amy J. Xu, Ariela Noy, Stephanie Lobaugh, Monica Chelius, Karen Chau, Carol Portlock, Carla Hajj, Brandon S. Imber, David J. Straus, Craig H. Moskowitz, Morton Coleman, Andrew D. Zelenetz, Zhigang Zhang, Ahmet Dogan

Blood Adv (2021) 5 (7): 1830–1836.

https://doi.org/10.1182/bloodadvances.2020003992

Published: 2021

Journal Articles

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

Blood Adv (2021) 5 (6): 1737–1745.

https://doi.org/10.1182/bloodadvances.2020002724

Published: 2021

Journal Articles

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Alexandra Schifferli, Andrea Heiri, Paul Imbach, Susanne Holzhauer, Markus G. Seidel, Diane Nugent, Marc Michel, Thomas Kühne

Blood Adv (2021) 5 (6): 1617–1626.

https://doi.org/10.1182/bloodadvances.2020003004

Published: 2021

Journal Articles

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation

Emily Baumrin, Natalie E. Izaguirre, Bruce Bausk, Monica M. Feeley, Camden P. Bay, Qiheng Yang, Vincent T. Ho, Lindsey R. Baden, Nicolas C. Issa

Blood Adv (2021) 5 (6): 1585–1593.

https://doi.org/10.1182/bloodadvances.2020003749

Published: 2021

Includes: Supplemental data

Journal Articles

Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome

Shruti Chaturvedi, Noor Dhaliwal, Sarah Hussain, Kathryn Dane, Harshvardhan Upreti, Evan M. Braunstein, Xuan Yuan, C. John Sperati, Alison R. Moliterno, Robert A. Brodsky

Blood Adv (2021) 5 (5): 1504–1512.

https://doi.org/10.1182/bloodadvances.2020003175

Published: 2021

Journal Articles

Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis

Blood Adv (2021) 5 (5): 1369–1378.

https://doi.org/10.1182/bloodadvances.2020003849

Published: 2021

Includes: Supplemental data

Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli

Blood Adv (2021) 5 (5): 1333–1339.

https://doi.org/10.1182/bloodadvances.2020003707

Published: 2021

Journal Articles

End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, David Belada, Angelo-Michele Carella, Neil Chua, Eva Gonzalez-Barca, Xiaonan Hong, Antonio Pinto, Yuankai Shi, Yoichi Tatsumi, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Sahin, Gila Sellam, Mikkel Z. Oestergaard, Umberto Vitolo, Marek Trněný

Blood Adv (2021) 5 (5): 1283–1290.

https://doi.org/10.1182/bloodadvances.2020002690

Published: 2021

Includes: Supplemental data

NARROW

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia

Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study

Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study

Involved-site radiotherapy for Helicobacter pylori –independent gastric MALT lymphoma: 26 years of experience with 178 patients

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation

Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome

Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only